Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,400.00 at JPMorgan Chase & Co.

Mettler-Toledo International (NYSE:MTD) had its price target lifted by JPMorgan Chase & Co. from $1,300.00 to $1,400.00 in a research note published on Monday morning, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical instruments supplier’s stock.

Other equities research analysts have also issued research reports about the stock. Jefferies Financial Group reaffirmed an underperform rating and issued a $1,250.00 price target (up previously from $1,230.00) on shares of Mettler-Toledo International in a research report on Monday, June 3rd. Robert W. Baird lifted their target price on Mettler-Toledo International from $1,212.00 to $1,360.00 and gave the company a neutral rating in a research report on Monday, May 13th. Evercore ISI upped their price target on Mettler-Toledo International from $1,375.00 to $1,390.00 and gave the stock an in-line rating in a report on Tuesday, July 2nd. Stifel Nicolaus raised their price objective on Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the company a buy rating in a research note on Monday. Finally, StockNews.com upgraded shares of Mettler-Toledo International from a hold rating to a buy rating in a research note on Thursday, July 11th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, Mettler-Toledo International has a consensus rating of Hold and a consensus target price of $1,343.75.

Mettler-Toledo International Trading Down 1.8 %

NYSE:MTD opened at $1,357.95 on Monday. Mettler-Toledo International has a 12 month low of $928.49 and a 12 month high of $1,546.93. The stock has a market capitalization of $29.00 billion, a price-to-earnings ratio of 38.08, a PEG ratio of 4.06 and a beta of 1.17. The firm has a fifty day simple moving average of $1,408.89 and a two-hundred day simple moving average of $1,331.78.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 EPS for the quarter, beating analysts’ consensus estimates of $9.00 by $0.65. Mettler-Toledo International had a negative return on equity of 590.80% and a net margin of 20.95%. The business had revenue of $946.75 million during the quarter, compared to analyst estimates of $929.13 million. During the same period in the previous year, the company posted $10.19 EPS. The firm’s revenue was down 3.6% compared to the same quarter last year. Equities analysts predict that Mettler-Toledo International will post 40.13 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the company’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $1,528.43, for a total transaction of $458,529.00. Following the sale, the chief financial officer now directly owns 4,914 shares of the company’s stock, valued at $7,510,705.02. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, CFO Shawn Vadala sold 300 shares of the business’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $1,528.43, for a total transaction of $458,529.00. Following the sale, the chief financial officer now directly owns 4,914 shares in the company, valued at approximately $7,510,705.02. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Gerry Keller sold 310 shares of the firm’s stock in a transaction dated Wednesday, May 15th. The stock was sold at an average price of $1,511.56, for a total value of $468,583.60. Following the completion of the transaction, the insider now owns 6 shares of the company’s stock, valued at approximately $9,069.36. The disclosure for this sale can be found here. In the last 90 days, insiders sold 3,278 shares of company stock worth $4,871,849. 1.94% of the stock is owned by company insiders.

Institutional Trading of Mettler-Toledo International

Several institutional investors and hedge funds have recently modified their holdings of MTD. Ground Swell Capital LLC bought a new position in shares of Mettler-Toledo International in the second quarter worth approximately $288,000. Daiwa Securities Group Inc. lifted its stake in shares of Mettler-Toledo International by 29.4% in the 2nd quarter. Daiwa Securities Group Inc. now owns 3,470 shares of the medical instruments supplier’s stock valued at $4,849,000 after acquiring an additional 788 shares during the last quarter. Choreo LLC purchased a new stake in Mettler-Toledo International during the 2nd quarter valued at about $661,000. Prudential PLC grew its position in Mettler-Toledo International by 3.6% during the 2nd quarter. Prudential PLC now owns 2,535 shares of the medical instruments supplier’s stock worth $3,543,000 after acquiring an additional 87 shares during the last quarter. Finally, Quest Partners LLC increased its stake in Mettler-Toledo International by 1,650.0% in the 2nd quarter. Quest Partners LLC now owns 105 shares of the medical instruments supplier’s stock worth $147,000 after purchasing an additional 99 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.